News Today

Benchmark Indices Edge Higher Despite Volatility, Nifty Nears 21,000

Copy Link

In terms of sectors, PSU Bank, FMCG, power, metal, and realty observed gains of 0.5-1 percent, while the pharma index saw a 0.4 percent decline.

• 11 December, 2023
• 3:15 PM
• less than a minute

USFDA issues warning letter to Intas Pharma for manufacturing lapses at Ahmedabad plant

Copy Link

The said manufacturing facility was under inspection from May 1 to May 12, 2023.

• 11 December, 2023
• 2:15 PM
• less than a minute

Indian Railways places a new order with Subros Ltd. for coach air conditioners

Copy Link

The company already provides Indian Railways with Rail Driver Cabin Air Conditioning Systems, and its strategic aim to grow its business

• 11 December, 2023
• 1:56 PM
• less than a minute

Sensex Hits Record 70,000 Mark, Nifty Tops 21,000 in Bank-Driven Rally

Copy Link

All sectoral indices, except pharma, experience positive trends, with media and PSU bank indices leading the way

• 11 December, 2023
• 1:54 PM
• less than a minute

Zydus and Daewoong Forge Exclusive Deal to Develop and Commercialize Leuprolide Acetate in the ...

Copy Link

Zydus aims to strengthen its complex injectable portfolio with the generic version of Lupron Depot, according to Managing Director Sharvil Patel

• 11 December, 2023
• 1:37 PM
• less than a minute

Warburg Pincus Plans Over Rs 5,000 Crore Share Sale in IDFC First Bank and Bharti Airtel

Copy Link

The move follows Warburg Pincus' complete exit from Computer Age Management Services Ltd (CAMS) earlier this week.

• 07 December, 2023
• 11:13 AM
• less than a minute

US FDA inspects plants owned by Laurus Labs, Sun Pharma, Torrent Pharma, and Dr. Reddy's

Copy Link

The USFDA issued a Form 483 after the inspection, which usually includes the observations made during the inspection. In this instance, the manufacturing facility in Gujarat made one observation.

• 07 December, 2023
• 10:56 AM
• less than a minute

Zydus Lifesciences Gains 2% on US FDA Nod for Heart Drug Ivabradin

Copy Link

The drug will be manufactured at Zydus' formulation facility in Ahmedabad.

• 06 December, 2023
• 3:16 PM
• less than a minute

Aclaris Therapeutics and a subsidiary of Sun Pharma collaborate on a licensing deal

Copy Link

Under the terms of the agreement, Aclaris granted Sun Pharma exclusive rights to certain patents pertaining to the use of deuruxolitinib

• 06 December, 2023
• 12:03 PM
• less than a minute

Markets Hit New Highs as Nifty Surpasses 20,650

Copy Link

With the exception of Nifty Pharma and Media, all other sectoral indices concluded the day in positive territory.

• 04 December, 2023
• 3:40 PM
• less than a minute